Plenary session 3: Revolutionizing healthcare: The current landscape of generative AI



Thursday 12 September


Session description:

Prepare to be captivated as Sara Siegel, Global Head of Healthcare at Deloitte, LLP, takes the stage as session chair to give a “state of the union” overview of what has happened in the last year and the current status of Generative AI in healthcare. Is it the gamechanger we have been banking on? Delve into the intricacies of Generative AI as we explore its impact on outcomes, staff, and equity – will it only be available to high income countries? Can it address the current gaps across the world?

What is working? Three global leaders from our membership will share their case studies of diverse use approaches including clinical care, patient experience, and operations. Gain takeaway insights to the challenges they are solving, their approach to implementations and the outcomes to date.

Chair: Ms Sara Siegel, Global Head of Healthcare, Deloitte, UK



Thursday 12 September


Chair and Speakers

Ms Sara Siegel

Global Head of Healthcare, Deloitte, UK

Sara is Deloitte’s Global Health Sector Leader and leads the health practice in the UK. This encapsulates the firm’s work with the payor and provider systems both publicly and privately funded.  Sara’s passion for health began when she moved to the UK in 2003 and was first exposed to the NHS.

Sara believes passionately in the mission of the NHS and sees the incredible value that a health service free at the point of need provides to society.  With her teams, she supports the NHS to do more and better with the resources at its disposal.  Some of Sara’s work includes supporting the government on its Coronavirus testing programme, and the introduction of robotic and cognitive automation to improve the speed and quality of NHS services and to release more time for direct patient care. It is the introduction and uptake of new innovative practices either pioneered by individuals or tested first in other health systems around the world that Sara most enjoys working with her NHS clients on.

In her global role, Sara is growing the firm’s presence in implementation of Electronic Health Records, and increasing the presence of AI and Generative AI in the firm’s work. She is also focused on health equity and sustainability and climate.

Sara is a trustee of the Peter Sowerby Foundation which supports healthcare causes and she is a trustee of the Conservation Collective, an environmental charity that promotes local teams working to solve environmental problems.

Prof. Dr Luís Abegão Pinto

Head of Glaucoma Unit, Unidade Local de Saúde Santa Maria, Portugal

Luís Abegão Pinto is a Portuguese Ophthalmologist with a PhD in Ocular Imaging. He has published more than 100 indexed papers – covering the field of glaucoma, diabetic retinopathy, imaging, and artificial intelligence. He is the Head of the Glaucoma Unit of Portugal’s largest hospital in Lisbon and currently serves as the Secretary of the European Glaucoma Society.

Prof. Aymeric Lim

CEO, National University Hospital, Singapore

Aymeric is the Chief Executive Officer of the National University Hospital in Singapore – a leading tertiary care hospital integrating education, research, and innovation to address both present and future healthcare challenges.

The 1,200-bed hospital is the principal teaching hospital of the School of Medicine and the Faculty of Dentistry of the National University of Singapore. It is Singapore’s only university hospital and a key member of the National University Health System, one of three public healthcare clusters in the country.

The hospital adopts a digital first strategy. It is part of the first public healthcare cluster to be fully integrated on NGEMR. Its success with integrating AI in patient care includes the use of an AI-based neuro imaging capability to expedite the identification of stroke patients; and a data dashboard network that provides “live” medical data of patients, enabling tracking of wait times and prediction of daily patient turnout, allowing for more informed decisions about how best to allocate resources. Another tool flags hypercalcaemia to clinicians in real time, prompting quicker interventions for patients. The hospital has set out an ambitious goal to be an AI-literate organisation by embedding innovations as a way of work and life to improve efficiency, and being creative in the delivery of healthcare.

A practising hand surgeon sub-specialising in peripheral nerve surgery, Aymeric’s work has earned him numerous awards, including the National Medical Excellence Awards – Outstanding Clinician Award.

Dr Michael Schlosser

SVP of Care Transformation and Innovation, HCA Healthcare, USA

Michael Schlosser, MD, MBA is the Senior Vice President of Care Transformation and Innovation for HCA Healthcare. Reporting directly to the CEO of HCA, he is responsible for leading care delivery innovation and transformation for the enterprise. His department’s vision is to design, develop, integrate, implement, and optimize technology and processes that drive care delivery with the common goal of improving the experience and outcomes for HCA Healthcare’s leaders, care teams, and patients. As part of this strategy, he leads the implementation and optimization of our electronic health record systems, HCA Healthcare’s data science and data strategy teams, and the enterprise Responsible AI program.

Prior to this role, he served as the group’s Chief Medical Officer – leading the clinical operations for 100 HCA hospitals, overseeing quality, patient outcomes, and clinical strategy. He has also served as the Chief Medical Officer for Healthtrust.

Dr Schlosser is a neurosurgeon and completed his residency and fellowship at Johns Hopkins, has served as a Medical Officer with the FDA, and holds a degree in Chemical Engineering from MIT and an MBA from Vanderbilt.